Abstract
As extracts from Ganoderma lucidum (G. lucidum, Lingzhi) have been reported to be an alternative adjuvant treatment for diabetes, numerous of work have been carried out on it. Among the many biologically active constituents of Ganoderma, polysaccharides, proteoglycans, proteins, and triterpenoids have been shown to have hypoglycemic effects. Based on our research and other references, this article discusses the antidiabetic effect of Ganoderma mediated by protecting pancreas islet; inhibiting protein tyrosine phosphatase 1B, a promising therapeutic target of diabetes; decreasing lymphocyte infiltration; and increasing the antibody detection of insulin in diabetic mice. This review summarizes researches about the hypoglycemic action effects of polysaccharides, proteoglycans, proteins, and triterpenoids from Ganoderma as a guide for future research on diabetes and its complications. In addition, clinical studies with diabetic indexes are reviewed.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Karaa A, Goldstein A (2015) The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes. Pediatr Diabetes 16(1):1–9
Butalia S, Kaplan GG, Khokhar B, Rabi DM (2016) Environmental risk factors and type 1 diabetes: past, present, and future. Can J Diabetes 40(6):586–593
Petzold A, Solimena M, Knoch KP (2015) Mechanisms of beta cell dysfunction associated with viral infection. Curr Diab Rep 15(10):73
Ripsin CM, Kang H, Urban RJ (2009) Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician 79(1):29–36
Tao Z, Shi A, Zhao J (2015) Epidemiological perspectives of diabetes. Cell Biochem Biophys 73(1):181–185
Riserus U, Willett WC, Hu FB (2009) Dietary fats and prevention of type 2 diabetes. Prog Lipid Res 48(1):44–51
Sanabria-Martinez G, Garcia-Hermoso A, Poyatos-Leon R, Alvarez-Bueno C, Sanchez-Lopez M, Martinez-Vizcaino V (2015) Effectiveness of physical activity interventions on preventing gestational diabetes mellitus and excessive maternal weight gain: a meta-analysis. BJOG 122(9):1167–1174
Cizmarikova M (2017) The efficacy and toxicity of using the Lingzhi or Reishi medicinal mushroom, G. lucidum (agaricomycetes), and its products in chemotherapy (review). Int J Med Mushrooms 19(10):861–877
Ahmad MF (2018) G. lucidum: persuasive biologically active constituents and their health endorsement. Biomed Pharmacother 107:507–519
Chen Y, Qiao J, Luo J, Wu F, Meng G, Chen H, Zheng H, Xu J (2011) Effects of G. lucidum polysaccharides on advanced glycation end products and receptor of aorta pectoralis in T2DM rats. Zhongguo Zhong Yao Za Zhi 36(5):624–627
Yang Z, Wu F, He Y, Zhang Q, Zhang Y, Zhou G, Yang H, Zhou P (2018) A novel PTP1B inhibitor extracted from G. lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway. Food Funct 9(1):397–406
Fatmawati S, Shimizu K, Kondo R (2010) Ganoderic acid Df, a new triterpenoid with aldose reductase inhibitory activity from the fruiting body of G. lucidum. Fitoterapia 81(8):1033–1036
Kino K, Mizumoto K, Sone T, Yamaji T, Watanabe J, Yamashita A, Yamaoka K, Shimizu K, Ko K, Tsunoo H (1990) An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice. Diabetologia 33(12):713–718
Radenkovic M, Stojanovic M, Prostran M (2016) Experimental diabetes induced by alloxan and streptozotocin: the current state of the art. J Pharmacol Toxicol Methods 78:13–31
Bach EE, Hi EMB, Martins AMC, Nascimento PAM, Wadt NSY (2018) Hypoglycemic and hypolipidemic effects of G lucidum in streptozotocin-induced diabetic rats. Medicines (Basel) 5(3):pii: E78
Lin CC, Yu YL, Shih CC, Liu KJ, Ou KL, Hong LZ, Chen JD, Chu CL (2011) A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells. Cancer Immunol Immunother 60(7):1019–1027
van der Hem LG, van der Vliet JA, Bocken CF, Kino K, Hoitsma AJ, Tax WJ (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 60(5):438–443
Zhang HN, He JH, Yuan L, Lin ZB (2003) In vitro and in vivo protective effect of G. lucidum polysaccharides on alloxan-induced pancreatic islets damage. Life Sci 73(18):2307–2319
He CY, Li WD, Guo SX, Lin SQ, Lin ZB (2006) Effect of polysaccharides from G. lucidum on streptozotocin-induced diabetic nephropathy in mice. J Asian Nat Prod Res 8(8):705–711
Li K, Yu M, Hu Y, Ren G, Zang T, Xu X, Qu J (2016) Three kinds of G. lucidum polysaccharides attenuate DDC-induced chronic pancreatitis in mice. Chem Biol Interact 247:30–38
Peterszegi G, Robert AM, Robert L (2003) Protection by L-fucose and fucose-rich polysaccharides against ROS-produced cell death in presence of ascorbate. Biomed Pharmacother 57(3–4):130–133
Li F, Zhang Y, Zhong Z (2011) Antihyperglycemic effect of G. lucidum polysaccharides on streptozotocin-induced diabetic mice. Int J Mol Sci 12(9):6135–6145
Zheng J, Yang B, Yu Y, Chen Q, Huang T, Li D (2012) G. lucidum polysaccharides exert anti-hyperglycemic effect on streptozotocin-induced diabetic rats through affecting beta-cells. Comb Chem High Throughput Screen 15(7):542–550
Temneanu OR, Trandafir LM, Purcarea MR (2016) Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice. J Med Life 9(3):235–239
Mazo VK, Sidorova YS, Zorin SN, Kochetkova AA (2016) Streptozotocin induced diabetes rat models. Vopr Pitan 85(4):14–21
Wang B, Chandrasekera PC, Pippin JJ (2014) Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes. Curr Diabetes Rev 10(2):131–145
Xiao C, Wu QP, Cai W, Tan JB, Yang XB, Zhang JM (2012) Hypoglycemic effects of G. lucidum polysaccharides in type 2 diabetic mice. Arch Pharm Res 35(10):1793–1801
Wang F, Zhou Z, Ren X, Wang Y, Yang R, Luo J, Strappe P (2015) Effect of G. lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats. Lipids Health Dis 14:49
Xiao C, Wu Q, Zhang J, Xie Y, Cai W, Tan J (2017) Antidiabetic activity of G. lucidum polysaccharides F31 down-regulated hepatic glucose regulatory enzymes in diabetic mice. J Ethnopharmacol 196:47–57
Yang Z, Chen C, Zhao J, Xu W, He Y, Yang H, Zhou P (2018) Hypoglycemic mechanism of a novel proteoglycan, extracted from G. lucidum, in hepatocytes. Eur J Pharmacol 820:77–85
Teng BS, Wang CD, Zhang D, Wu JS, Pan D, Pan LF, Yang HJ, Zhou P (2012) Hypoglycemic effect and mechanism of a proteoglycan from G. lucidum on streptozotocin-induced type 2 diabetic rats. Eur Rev Med Pharmacol Sci 16(2):166–175
Wang CD, Teng BS, He YM, Wu JS, Pan D, Pan LF, Zhang D, Fan ZH, Yang HJ, Zhou P (2012) Effect of a novel proteoglycan PTP1B inhibitor from G. lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice. Br J Nutr 108(11):2014–2025
Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P (2013) Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from G. lucidum fruiting bodies on db/db mice and the possible mechanism. PLoS One 8(7):e68332
Thyagarajan-Sahu A, Lane B, Sliva D (2011) ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complement Altern Med 11:74
Heng LZ, Comyn O, Peto T, Tadros C, Ng E, Sivaprasad S, Hykin PG (2013) Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med 30(6):640–650
Papadopoulou-Marketou N, Paschou SA, Marketos N, Adamidi S, Adamidis S, Kanaka-Gantenbein C (2018) Diabetic nephropathy in type 1 diabetes. Minerva Med 109(3):218–228
Roman-Pintos LM, Villegas-Rivera G, Rodriguez-Carrizalez AD, Miranda-Diaz AG, Cardona-Munoz EG (2016) Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. J Diabetes Res 2016:3425617
Okonkwo UA, DiPietro LA (2017) Diabetes and wound angiogenesis. Int J Mol Sci 18(7):pii: E1419
Tesch GH (2017) Diabetic nephropathy – is this an immune disorder? Clin Sci (Lond) 131(16):2183–2199
Hussain N, Adrian TE (2017) Diabetic neuropathy: update on pathophysiological mechanism and the possible involvement of glutamate pathways. Curr Diabetes Rev 13(5):488–497
Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215–2222
Lim JZ, Ng NS, Thomas C (2017) Prevention and treatment of diabetic foot ulcers. J R Soc Med 110(3):104–109
O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX, Anderson JL, Jacobs AK, Halperin JL, Albert NM, Brindis RG, Creager MA, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Kushner FG, Ohman EM, Stevenson WG, Yancy CW, American College of Cardiology Foundation/American Heart Association Task Force on Practice G (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127(4):e362–e425
Zhu KX, Nie SP, Li C, Gong D, Xie MY (2014) Ganoderma atrum polysaccharide improves aortic relaxation in diabetic rats via PI3K/Akt pathway. Carbohydr Polym 103:520–527
Tie L, Yang HQ, An Y, Liu SQ, Han J, Xu Y, Hu M, Li WD, Chen AF, Lin ZB, Li XJ (2012) G. lucidum polysaccharide accelerates refractory wound healing by inhibition of mitochondrial oxidative stress in type 1 diabetes. Cell Physiol Biochem 29(3–4):583–594
Cheng PG, Phan CW, Sabaratnam V, Abdullah N, Abdulla MA, Kuppusamy UR (2013) Polysaccharides-rich extract of G. lucidum (M.A. Curtis:Fr.) P. Karst accelerates wound healing in streptozotocin-induced diabetic rats. Evid Based Complement Alternat Med 2013:671252
Pan D, Zhang D, Wu J, Chen C, Xu Z, Yang H, Zhou P (2014) A novel proteoglycan from G. lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice. Food Chem Toxicol 63:111–118
Zhu KX, Nie SP, Tan LH, Li C, Gong DM, Xie MY (2016) A polysaccharide from Ganoderma atrum improves liver function in type 2 diabetic rats via antioxidant action and short-chain fatty acids excretion. J Agric Food Chem 64(9):1938–1944
Li SH, Wu HX (2011) Clinical analysis of BoZhi Glycopeptide injection in treating diabetic foot. J Hainan Med Coll 17(10):1333–1334
Chu TT, Benzie IF, Lam CW, Fok BS, Lee KK, Tomlinson B (2012) Study of potential cardioprotective effects of G. lucidum (Lingzhi): results of a controlled human intervention trial. Br J Nutr 107(7):1017–1027
Klupp NL, Kiat H, Bensoussan A, Steiner GZ, Chang DH (2016) A double-blind, randomised, placebo-controlled trial of G. lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep 6:29540
Fan CH, Tong L, Zhang D, Zheng M, Yuan SS, Zhang C, He Q (2018) Effect of G. lucidum granules on glucose metabolism in patients with type 2 diabetes mellitus and its mechanism of action on inflammatory factors. Hebei J Tradit Chin Med 40(2):214–217
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Liu, Q., Tie, L. (2019). Preventive and Therapeutic Effect of Ganoderma (Lingzhi) on Diabetes. In: Lin, Z., Yang, B. (eds) Ganoderma and Health. Advances in Experimental Medicine and Biology, vol 1182. Springer, Singapore. https://doi.org/10.1007/978-981-32-9421-9_8
Download citation
DOI: https://doi.org/10.1007/978-981-32-9421-9_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9420-2
Online ISBN: 978-981-32-9421-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)